WHO Expert Committee on Specifications for Pharmaceutical Preparations : forty-eighth meeting report /

WHO Expert Committee on Specifications for Pharmaceutical Preparations thirty-ninth report.
منشور في: (2005)

WHO Expert Committee on Biological Standardization : sixtieth report /
منشور في: (2013)

WHO Expert Committee on Biological Standardization fifty-sixth report.
منشور في: (2007)

WHO Expert Committee on Biological Standardization fifty-second report.
منشور في: (2004)

WHO Expert Committee on Biological Standardization fifty-fourth report.
منشور في: (2005)

WHO Expert Committee on Biological Standardization : sixty-first report.
منشور في: (2013)

Who Expert Committee on Biological Standardization : sixty-second report.
منشور في: (2013)

Safe handling of hazardous drugs /
منشور في: (2011)

The selection and use of essential medicines report of the WHO Expert Committee, 2002.
منشور في: (2003)

The selection and use of essential medicines report of the WHO Expert Committee, 2003 ; (including the 13th Model List of Essential Medicines).
منشور في: (2004)

Extractables & Leachables for Pharmaceutical Products 2011 : [conference proceedings] : Dublin, Ireland, 27-28 September 2011 /
منشور في: (2011)

Good manufacturing practices for pharmaceuticals a plan for total quality control from manufacturer to consumer /
حسب: Willig, Sidney H., 1919-
منشور في: (2000)

Leachables and extractables handbook safety evaluation, qualification, and best practices applied to inhalation drug products /
منشور في: (2012)

WHO Expert Committee on Biological Standardization : sixty-third report. /
منشور في: (2014)

Organelle-specific pharmaceutical nanotechnology
منشور في: (2010)

Extractables & Leachables : [E & L 2012 conference proceedings] : delivering pharmaceuticals safely : 12-13 December 2012, Vienna, Austria /
منشور في: (2012)

E & L USA : Extractables & Leachables : [conference proceedings] : delivering pharmaceuticals safely : 7-9 May 2013, Providence, RI, USA /
منشور في: (2013)

The selection and use of essential medicines
منشور في: (2006)

Towards drugs of the future key issues in lead finding and lead optimization /
منشور في: (2008)

Pharmaceutical blending and mixing /
منشور في: (2015)

Measuring transparency to improve good governance in the public pharmaceutical sector.
منشور في: (2009)

Measuring transparency to improve good governance in the public pharmaceutical sector.
منشور في: (2009)

Coherence for health innovation for new medicines for infectious diseases.
منشور في: (2009)

Modified-release drug delivery technology.
منشور في: (2008)

Modified-release drug delivery technology.
منشور في: (2008)

Pharmaceutical production facilities design and applications /
حسب: Cole, Graham, 1934-
منشور في: (1998)

Manufacturing of pharmaceutical proteins : from technology to economy /
حسب: Behme, Stefan
منشور في: (2015)

The greening of pharmaceutical engineering. practice, analysis, and methodology /
حسب: Islam, Rafiqul, 1959-
منشور في: (2015)

Pharmaceutical industry innovation and developments /
منشور في: (2011)

Drugs : from discovery to approval /
حسب: Ng, Rick
منشور في: (2015)

ADME-enabling technologies for drug design and development
منشور في: (2012)

Dosage calculations /
حسب: Pickar, Gloria D
منشور في: (2004)

Pharmaceutical pricing policies in a global market
منشور في: (2008)

Regulating pharmaceuticals in Europe striving for efficiency, equity and quality /
منشور في: (2004)

IFLA cataloguing principles steps towards an international cataloguing code, 3 : report from the 3rd IFLA Meeting of Experts on an International Cataloguing Code, Cairo, Egypt, 2005 /
منشور في: (2006)

IFLA cataloguing principles steps towards an international cataloguing code, 4 : report from the 4th IFLA Meeting of Experts on an International Cataloguing Code, Seoul, Korea, 2006 /
منشور في: (2007)